The Ministry of Health, Welfare and Family Affairs is trying to cut a deal with Roche Korea, a Korean unit of Swiss based multinational firm, over the possible of Fuzeon, a new drug for AIDS, according to pharmaceutical sources.
Fuzeon, the first of a novel class of antiretroviral drugs, costs an estimated USD$25,000 per year in the United States. Its cost and inconvenient dosing regimen are...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.